Inspire Medical Systems (INSP) Debt to Equity (2017 - 2022)

Inspire Medical Systems has disclosed Debt to Equity across 6 years of filings, most recently posting $0.04 for Q2 2022.

• Debt to Equity for Q2 2022 came in at $0.04, down 56.47% year-over-year; the trailing twelve-month figure through Jun 2022 was $0.04 (down 56.47% YoY), and the FY2021 annual result was $0.07, down 35.96% from the prior year.
• Debt to Equity came in at $0.04 for Q2 2022 at Inspire Medical Systems, down from $0.06 in the prior quarter.
• In the past five years, Debt to Equity ranged from a high of $0.25 in Q3 2018 to a low of -$4.84 in Q1 2018.
• The 5-year median for Debt to Equity is $0.11 (2020), against an average of -$0.14.
• Across the five-year window, Debt to Equity tumbled 98.77% in 2018 and surged 103.2% in 2019, its largest moves.
• Inspire Medical Systems' Debt to Equity stood at $0.15 in 2018, then advanced by 15.38% to $0.18 in 2019, then tumbled by 38.58% to $0.11 in 2020, then slumped by 35.96% to $0.07 in 2021, then tumbled by 37.44% to $0.04 in 2022.
• The last three Debt to Equity figures came in at $0.04 (Q2 2022), $0.06 (Q1 2022), and $0.07 (Q4 2021), per Business Quant data.